CW October 2003
Volume 12Issue Number 10 October 2003 ISSN 10593802 Letrozole Clinical Trial for Breast Cancer Halted EarlyA Canadian-led international clinical trial has found that postmenopausal survivors of early stage breast cancer who took the drug letrozole after completing an initial five years of tamoxifen therapy had a significantly reduced risk of cancer recurrence compared to women taking a placebo.
Go to Previous Page Go to Next Page Source & Additional Reading P. Gross et al., New England Journal of Medicine (Online), October 9, 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
